Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma
Suiqing Zhou, Liren Zhang, Yue You, et al.
Journal of Hepatology (2025)
Closed Access
Comprehensive molecular characteristics of hepatocellular carcinoma based on multi-omics analysis
Yingying Wang, Wan-Xia Yang, Jianhui Cai, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis
Renyi Su, Chen-Hao Xu, Haijun Guo, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Prognostic iron-metabolism signature robustly stratifies single-cell characteristics of hepatocellular carcinoma
Zhipeng Zhu, Cao Huang, Hongyu Yan, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 929-941
Open Access | Times Cited: 2
The switch triggering the invasion process: Lipid metabolism in the metastasis of hepatocellular carcinoma
Jiaqian Zhang, Zhicheng Zhang, Zhangfan Wu, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 11, pp. 1271-1284
Open Access | Times Cited: 2
The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma
Qing-Jian Xie, Yuan Zeng, Xiangting Zhang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 9
Open Access | Times Cited: 2
Lipidomics reveals the lipid-lowering and hepatoprotective effects of Celosia Semen on high-fat diet-induced NAFLD mice
Jin‐Quan Zhao, Zhou Qiqi, Ke Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118922-118922
Closed Access | Times Cited: 2
Actions of thyroid hormones and thyromimetics on the liver
Rohit A. Sinha, Eveline Bruinstroop, Paul M. Yen
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 2
PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity
Eduardo Hideo Gilglioni, Ao Li, Wadsen St‐Pierre‐Wijckmans, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Exploiting acquired vulnerability to develop novel treatments for cholangiocarcinoma
Sirayot Areewong, Orawan Suppramote, Sunisa Prasopporn, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The role of metabolic reprogramming in liver cancer and its clinical perspectives
Mengxiao Lu, Yingjie Wu, Min Xia, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Identifying Proteins and Amino Acids Associated with Liver Cancer Risk: A Study Utilizing Mendelian Randomization and Bulk RNA Sequencing Analysis
Chi Ma, Ling Tang, Jiaqi Yao, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 262-262
Open Access | Times Cited: 1
Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy
Yuting Gao, Yi Gong, Junlan Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy
Xianmei Lv, Gaochen Lan, Lujian Zhu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1265-1278
Open Access | Times Cited: 1
Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism
Rui Kong, Nan Wang, Chunli Zhou, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2533-2533
Open Access | Times Cited: 1
Epigenetic repression of de novo cysteine synthetases induces intra-cellular accumulation of cysteine in hepatocarcinoma by up-regulating the cystine uptake transporter xCT
Tomoaki Yamauchi, Yumi Okano, Daishu Terada, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
The crosstalk between cellular survival pressures and N6-methyladenosine modification in hepatocellular carcinoma
Chu‐Li Fu, Zhengwei Zhao, Qiangnu Zhang
Hepatobiliary & pancreatic diseases international (2024)
Closed Access | Times Cited: 1
Targeting Hepatocellular Carcinoma Growth and Metabolism: A Synergistic Approach with Para-Toluenesulfonamide and Radiofrequency Ablation
Liu Na, Jianzeng Zhang, Jiaojiao Wu, et al.
iLiver (2024) Vol. 3, Iss. 3, pp. 100111-100111
Open Access | Times Cited: 1
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinoma
Yanran Bi, Xihui Ying, Wanbin Chen, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Histone Lactylation-Driven YTHDC1 Promotes Hepatocellular Carcinoma Progression via Lipid Metabolism Remodeling
Wenfei Du, Sheng Tan, Yonglin Peng, et al.
Cancer Letters (2024), pp. 217426-217426
Closed Access | Times Cited: 1
SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A‐mediated SLC7A11 expression and promoting aerobic glycolysis
Rong Li, Shunle Li, Lin Shen, et al.
Environmental Toxicology (2023) Vol. 39, Iss. 3, pp. 1269-1282
Closed Access | Times Cited: 3
A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
Shasha Wang, Songying Zhang
Reproductive Sciences (2023) Vol. 31, Iss. 2, pp. 514-531
Closed Access | Times Cited: 2
Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives
Caiyi Cherry Li, Meng Liu, Hsin-Pei Lee, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 133-146
Closed Access
Sweet dreams could be made of this: carbohydrate‐responsive element‐binding protein (ChREBP) as a target for hepatocellular carcinoma therapy
Maite G. Fernández‐Barrena, Matías A. Ávila
Molecular Oncology (2024)
Open Access
CMTM6 mediates the Warburg effect and promotes the liver metastasis of colorectal cancer
Aurpita Shaha, Yuanguo Wang, Xianghu Wang, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 9, pp. 2002-2015
Open Access

Scroll to top